Insider filing · TYRA

RA Capital Healthcare Fund LP bought $19.8M of Tyra Biosciences (TYRA)

Executed Nov 8 2024, disclosed Nov 13 2024, 5 days later.

Over the 21 trading sessions from the disclosed entry session (Nov 13 2024), the stock returned -6.6% (delay-adjusted); from the execution session (Nov 8 2024), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

RL RA Capital Healthcare Fund LP Director profile →

RA Capital Healthcare Fund LP (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in TYRA. The largest single filing was $58.4M of FULC (4,175,139 sh across 3 lots, as filed), executed Dec 8 2025.

TYRA TYRA TYRA · 21 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→